Alyeska Investment Group
DOCS icon

Alyeska Investment Group’s Doximity DOCS Stock Holding History

Alyeska Investment Group’s Portfolio DOCS Stock Details DOCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-408,718
Closed -$18.1M – 648
2025
Q4 		$18.1M Buy
+408,718
New +$22.9M 0.05% 324
2024
Q1 		– Sell
-200,000
Closed -$5.61M – 503
2023
Q4 		$5.61M Buy
+200,000
New +$4.72M 0.04% 302
2023
Q3 		– Sell
-245,000
Closed -$8.33M – 529
2023
Q2 		$8.33M Buy
245,000
+10,000
+4% +$333K 0.06% 286
2023
Q1 		$7.61M Buy
+235,000
New +$7.8M 0.07% 267
2022
Q4 		– Sell
-400,000
Closed -$12.1M – 443
2022
Q3 		$12.1M Buy
400,000
+50,000
+14% +$1.83M 0.14% 183
2022
Q2 		$12.2M Hold
350,000
– – 0.14% 190
2022
Q1 		$18.2M Buy
350,000
+65,000
+23% +$3.27M 0.2% 158
2021
Q4 		$14.3M Buy
285,000
+35,000
+14% +$2.28M 0.16% 162
2021
Q3 		$20.2M Hold
250,000
– – 0.25% 113
2021
Q2 		$14.6M Buy
+250,000
New +$14M 0.17% 167

Other funds holding DOCS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group's DOCS Position: Q1 2026 in Review

Alyeska Investment Group sold out of Doximity (DOCS) in Q1 2026, closing a stake of 408,718 shares — an estimated $18.1M sold.

Alyeska Investment Group first reported a position in DOCS in Q2 2021 and held it in 10 quarters. The position peaked at $20.2M in Q3 2021. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Alyeska Investment Group reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 408,718 Doximity shares in Q1 2026, an estimated $18.1M.
  • Alyeska Investment Group first reported a position in Doximity in Q2 2021 and held it in 10 quarters.
  • Alyeska Investment Group's Doximity position peaked at $20.2M in Q3 2021.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.